Berhane Ghebrehiwet
#166,634
Most Influential Person Now
Researcher
Berhane Ghebrehiwet's AcademicInfluence.com Rankings
Berhane Ghebrehiwetengineering Degrees
Engineering
#7395
World Rank
#8765
Historical Rank
Electrical Engineering
#2310
World Rank
#2418
Historical Rank
Berhane Ghebrehiwetcomputer-science Degrees
Computer Science
#10058
World Rank
#10551
Historical Rank
Computational Linguistics
#2519
World Rank
#2544
Historical Rank
Machine Learning
#4571
World Rank
#4622
Historical Rank
Artificial Intelligence
#4930
World Rank
#4994
Historical Rank
Download Badge
Engineering Computer Science
Berhane Ghebrehiwet's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Berhane Ghebrehiwet Influential?
(Suggest an Edit or Addition)Berhane Ghebrehiwet's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells (2001) (1209)
- Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q (1994) (349)
- gC1q‐R/p32, a C1q‐binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes (2000) (310)
- C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition1 (2008) (243)
- Activation of the classical pathway of complement by Hageman factor fragment (1981) (237)
- Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). (1996) (221)
- Complement activation on platelets: implications for vascular inflammation and thrombosis. (2010) (207)
- Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets (2000) (202)
- Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. (1983) (193)
- Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. (1983) (183)
- gC1q‐R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection (2001) (179)
- The plasma bradykinin-forming pathways and its interrelationships with complement. (2010) (177)
- Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. (1992) (167)
- The Binding Protein for Globular Heads of Complement C1q, gC1qR (1996) (146)
- Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity (1993) (140)
- cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. (2004) (139)
- An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development (2010) (126)
- Blood platelets activate the classical pathway of human complement (2006) (119)
- C1q as a unique player in angiogenesis with therapeutic implication in wound healing (2014) (118)
- Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. (1985) (116)
- Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. (1994) (115)
- C3e: an acidic fragment of human C3 with leukocytosis-inducing activity. (1979) (109)
- Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. (2009) (99)
- Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. (1994) (98)
- Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. (2008) (95)
- Cooperation of C1q Receptors and Integrins in C1q-Mediated Endothelial Cell Adhesion and Spreading1 (2002) (94)
- The C1q Family of Proteins: Insights into the Emerging Non-Traditional Functions (2012) (93)
- Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations (2016) (92)
- Expression of complement components and inhibitors on platelet microparticles (2008) (88)
- Platelet mediated complement activation. (2008) (87)
- Receptor for the globular heads of C1q (gC1q‐R, p33, hyaluronan‐binding protein) is preferentially expressed by adenocarcinoma cells (2004) (83)
- Protein Kinase C μ Is Regulated by the Multifunctional Chaperon Protein p32* (2000) (82)
- Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. (1995) (82)
- Structure and function of gC1q-R: a multiligand binding cellular protein. (1998) (80)
- Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. (1999) (79)
- The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. (1997) (79)
- Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. (2006) (79)
- The contribution of gC1qR/p33 in infection and inflammation. (2007) (76)
- Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. (1995) (74)
- Identification of a novel 33-kDa C1q-binding site on human blood platelets. (1994) (72)
- Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization (1984) (72)
- High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes (2006) (72)
- Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. (1996) (69)
- Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage1 (2009) (69)
- Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies (2009) (69)
- Interaction of high molecular weight kininogen binding proteins on endothelial cells (2003) (67)
- Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex. (1997) (66)
- C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. (1998) (64)
- The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. (1997) (63)
- Factor XII-dependent Contact Activation on Endothelial Cells and Binding Proteins gC1qR and Cytokeratin 1 (2001) (61)
- DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. (2012) (60)
- gC1q-R/p33: structure-function predictions from the crystal structure. (2002) (60)
- Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity (2010) (60)
- Cross-talk between the complement and the kinin system in vascular permeability. (2011) (59)
- The Hemopexin-like C-terminal Domain of Membrane Type 1 Matrix Metalloproteinase Regulates Proteolysis of a Multifunctional Protein, gC1qR* (2002) (57)
- Activation-dependent surface expression of gC1qR/p33 on human blood platelets (2003) (57)
- Maturation-dependent expression of C1q binding proteins on the cell surface of human monocyte-derived dendritic cells. (2003) (54)
- The cytoplasmic tail peptide sequence of membrane type‐1 matrix metalloproteinase (MT1‐MMP) directly binds to gC1qR, a compartment‐specific chaperone‐like regulatory protein (2002) (54)
- Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. (2015) (54)
- Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. (2004) (53)
- Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines. (1999) (53)
- Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. (1996) (52)
- Human blood platelets possess specific binding sites for C1q. (1987) (52)
- Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. (2004) (52)
- The N-terminal conserved domain of rubella virus capsid interacts with the C-terminal region of cellular p32 and overexpression of p32 enhances the viral infectivity. (2002) (50)
- Activation of the Kinin-Forming Cascade on the Surface of Endothelial Cells (2001) (50)
- cC1qR/CR and gC1qR/p33: observations in cancer. (2014) (50)
- Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response. (1990) (49)
- gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation. (2006) (49)
- Complement component C1q and its receptor are involved in the interaction of human sperm with zona‐free hamster eggs (1991) (49)
- Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. (1990) (49)
- Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. (1998) (48)
- Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by Surface Plasmon Resonance (BiaCore) (2011) (45)
- Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. (2013) (45)
- Human C1q induces eosinophil migration. (1996) (44)
- Isolation of a human endothelial cell C1q receptor (C1qR) (1993) (44)
- INTERACTION OF THE CLOTTING, KININ‐FORMING, COMPLEMENT, AND FIBRINOLYTIC PATHWAYS IN INFLAMMATION (1982) (44)
- Two parallel routes of the complement‐mediated antibody‐dependent enhancement of HIV‐1 infection (1997) (43)
- Platelet Glycoprotein Ib: A Zinc-Dependent Binding Protein for the Heavy Chain of High-Molecular-Weight Kininogen (1999) (42)
- The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1. (2019) (42)
- C1q augments platelet activation in response to aggregated Ig. (1997) (42)
- gC1qR Expression in Normal and Pathologic Human Tissues (2012) (41)
- The complement and contact activation systems: partnership in pathogenesis beyond angioedema (2016) (40)
- Activation of the alternative pathway of complement by monosodium urate crystals. (1983) (40)
- Participation of C1q and its receptor in adherence of human diploid fibroblast. (1990) (40)
- gC1qR/p33 Blockade Reduces Staphylococcus aureus Colonization of Target Tissues in an Animal Model of Infective Endocarditis (2006) (39)
- Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress. (2008) (38)
- Human blood platelet gC1qR/p33 (2001) (37)
- Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. (1999) (37)
- Classical pathway complement activation on human endothelial cells. (2007) (36)
- Characterization of the third component of complement (C3) after activation by cigarette smoke. (1987) (35)
- Lysis of C1Q-coated chicken erythrocytes by human lymphoblastoid cell lines. (1978) (35)
- The complement system: an evolution in progress (2016) (34)
- Reversible biotinylation of C1q with a cleavable biotinyl derivative. Application in C1q receptor (C1qR) purification. (1988) (34)
- The exosporium of B. cereus contains a binding site for gC1qR/p33: implication in spore attachment and/or entry. (2007) (32)
- Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells. (2003) (31)
- Trichinella spiralis: activation of complement by infective larvae, adults, and newborn larvae. (1992) (31)
- Soluble gC1qR Is an Autocrine Signal That Induces B1R Expression on Endothelial Cells (2014) (30)
- Monocyte Expressed Macromolecular C1 and C1q Receptors as Molecular Sensors of Danger: Implications in SLE (2014) (30)
- C1q as an autocrine and paracrine regulator of cellular functions. (2017) (30)
- The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization. (1999) (29)
- Functions associated with the C1q receptor. (1989) (29)
- Characterisation of the rat and mouse homologues of gC1qBP, a 33 kDa glycoprotein that binds to the globular `heads' of C1q (1997) (27)
- Human epithelial cell processing of carbon and gold nanoparticles (2008) (27)
- Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation (2004) (26)
- The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. (1981) (26)
- Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils. (1994) (26)
- Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32. (2000) (24)
- Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. (1985) (23)
- Cell Surface Expression and Function of the Macromolecular C1 Complex on the Surface of Human Monocytes (2011) (23)
- Smooth muscle and epithelial cells express specific binding sites for the C1q component of complement. (1992) (23)
- The role of complement in cigarette smoke-induced chemotactic activity of lung fluids. (1986) (23)
- Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology. (2020) (22)
- Platelet membrane receptors for the complement component C1q. (1994) (22)
- Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b. (1979) (22)
- C1q inhibits the expression of B lymphoblastoid cell line interleukin 1 (IL 1). (1987) (21)
- Faculty Opinions recommendation of C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. (2011) (21)
- Characterization of the murine gene of gC1qBP, a novel cell protein that binds the globular heads of C1q, vitronectin, high molecular weight kininogen and factor XII. (1998) (21)
- Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis (2021) (21)
- A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin‐forming enzymes (2015) (21)
- Structural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q (2016) (20)
- Surface Expression of Complement Receptor gC1q-R/p33 Is Increased on the Plasma Membrane of Human Spermatozoa after Capacitation1 (2002) (20)
- Faculty Opinions recommendation of Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. (2016) (19)
- Generation of Multiple Fluid-Phase C3b:Plasma Protein Complexes during Complement Activation: Possible Implications in C3 Glomerulopathies (2014) (19)
- C1q inhibitor (C1qINH): functional properties and possible relationship to a lymphocyte membrane-associated C1q precipitin. (1981) (18)
- Reticuloendothelial system fc receptor function in rheumatoid arthritis. (1983) (18)
- The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation. (1998) (18)
- Identification and partial characterization of human platelet C1q binding sites. (1988) (18)
- Targeting gC1qR domains for therapy against infection and inflammation. (2013) (17)
- Pathways of kinin formation and role in allergic diseases. (1989) (17)
- Soluble gC1qR in Blood and Body Fluids: Examination in a Pancreatic Cancer Patient Cohort (2015) (17)
- Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy. (2016) (17)
- Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. (2001) (17)
- A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen. (1994) (17)
- Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR). (1986) (16)
- Assignment of C1QBP encoding the C1q globular domain binding protein (gC1q-R) to human chromosome 17 band p13.3 by in situ hybridization. (1997) (16)
- Detection of complement C1q receptors on human spermatozoa. (1998) (16)
- Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium. (2011) (16)
- Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors. (2011) (16)
- Structure–Function Studies Using Deletion Mutants Identify Domains of gC1qR/p33 as Potential Therapeutic Targets for Vascular Permeability and Inflammation (2011) (15)
- SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems (2021) (15)
- Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and integrins. (2003) (15)
- Modulation of platelet responses to collagen by Clq receptors. (1990) (15)
- Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR (2016) (13)
- The release of lysosomal enzymes from human polymorphonuclear leukocytes by human C3e. (1984) (13)
- The kallikrein-kinin system in inflammation. (1989) (13)
- Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes. (1982) (13)
- GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells (2020) (13)
- Trimeric reassembly of the globular domain of human C1q. (2008) (13)
- Endothelial Cell Inflammatory Reactions Are Altered in the Presence of E-Cigarette Extracts of Variable Nicotine (2017) (12)
- Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients (2020) (12)
- Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG. (1992) (12)
- Does C-2 kinin exist? (2005) (12)
- C1q and C1q receptors (gC1qR and cC1qR) as potential novel targets for therapy against breast cancer (2018) (11)
- The Human gC1qR/p32 Gene, C1qBP (2001) (11)
- Description of an Acidic Fragment (C3e) of Human C3 Having Leukocytosis-Producing Activity (1978) (11)
- Complement C1q inhibits cellular spreading and stimulates adenylyl cyclase activity of fibroblasts. (1998) (11)
- C1q induces in vivo angiogenesis and promotes wound healing (2011) (11)
- The fifth component of complement (C5) is necessary for maximal pulmonary leukocytosis in mice chronically exposed to cigarette smoke. (1987) (10)
- Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators. (1984) (10)
- Activation of the Plasma Kinin Forming Cascade along Cell Surfaces (2001) (9)
- Zinc induces exposure of hydrophobic sites in the C-terminal domain of gC1q-R/p33. (2002) (9)
- Short amino acid sequences derived from C1q receptor (C1q‐R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV (1992) (9)
- The C1q-R participates in immunoregulation and signal transduction. (1993) (9)
- High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR , Mac-1 , and gC 1 qR in Monocytes (2006) (9)
- SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts (2021) (9)
- The combined effect of sidestream smoke and dynamic shear stress on endothelial cell inflammatory responses. (2015) (9)
- Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission (2016) (8)
- gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma (2020) (8)
- Is the A-Chain the Engine That Drives the Diversity of C1q Functions? Revisiting Its Unique Structure (2018) (8)
- C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and function. (1993) (7)
- Enhanced recognition of plasma proteins in a non-native state by complement C3b. A possible clearance mechanism for damaged proteins in blood. (2015) (7)
- Expression of functional cell surface C1-inactivator by U937 cells. (1988) (7)
- The intrinsic coagulation/kinin pathway--the classical complement pathway and their interactions. (1986) (7)
- Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy (2019) (7)
- ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (7)
- SARS-CoV-2 Structural Proteins Exposure Alter Thrombotic and Inflammatory Responses in Human Endothelial Cells (2021) (6)
- SLE: Novel Postulates for Therapeutic Options (2020) (6)
- Faculty Opinions recommendation of Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes. (2011) (6)
- The role of complement in the tumor microenvironment (2021) (5)
- Complement proteins in unexpected places: why we should be excited, not concerned! (2020) (5)
- Iconographies supplémentaires de l'article : Factor XII–independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II (2013) (5)
- CHARACTERIZATION OF HUMAN PLATELET ClQ BINDING SITES (1987) (5)
- Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer (2020) (5)
- Purification of C1q receptors and functional analysis. (2014) (4)
- The Complement System: Mechanisms of Activation, Regulation and Role in Innate and Adaptive Immunity (2009) (4)
- Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans (2021) (4)
- Carbon Nanotube Membrane Probes:Immuno-Labeling by LM, AFM, Tem, & FESEM (2002) (4)
- C1q is a molecular switch dictating the monocyte to dendritic cell (DC) transition and arrests DCs in an immature phenotype (2008) (3)
- Biochemical and functional comparison of platelet and raji cell clq receptors. (1992) (3)
- Platelet activation by clq multimers: Involvement of two distinct Clq receptors (1993) (3)
- Heterozygous P32/C1QBP/HABP1 Polymorphism rs56014026 Reduces Mitochondrial Oxidative Phosphorylation and Is Expressed in Low-grade Colorectal Carcinomas (2021) (3)
- Nonspecific Stimulation by Inactivated or Ultrasonicated Brucella Abortus (1974) (3)
- Bacillus and Clostridium Spore Attachment/ Entry of Human Colon Cells (2003) (3)
- Platelet Activation by Clq Results in the Induction of C Ub//33 Integrlns (GPIlb-rlla) and the Expression of P-Selectin and Procoagulant Activity (2003) (3)
- Expression and distribution of the complementreceptor gC1qR in bovine sperm (2008) (2)
- Expression and distribution of the complement receptor gC1qR in bovine esperm. (2008) (2)
- Yao Syndrome: A Potential Role and Association of Vasoactive Intestinal Peptide with NOD2 (2021) (2)
- Subject Index, Vol. 77, 1997 (1997) (2)
- Spreading in C 1 q-Mediated Endothelial Cell Adhesion Cooperation of C 1 q Receptors and Integrins and Berhane Ghebrehiwet (2002) (2)
- C1q binds phosphatidylserine and likely acts as an early bridging molecule in apoptotic cell recognition and clearance (2007) (2)
- Isolation and molecular characterization of a 33 kDa cell surface protein which binds to the globular “heads” of C1q (gC1q-R) (1993) (2)
- 162Evidence that the full-length gC1qR (residues 1-282) is expressed on the cell surface (2010) (2)
- Microbial Protein Binding to gC1qR Drives PLA2G1B-Induced CD4 T-Cell Anergy (2022) (2)
- Visual evoked potentials altered by serum IgG of patients with multiple sclerosis (1984) (2)
- P144C1q is a molecular switch that regulates dendritic cell maturation at the monocyte-to-dendritic cell transition (2008) (2)
- Editorial: C1q: A Molecular Bridge to Innate and Adaptive Immunity (2020) (1)
- Evidence that gC1qR and DC-SIGN associate on the surface of immature dendritic cells (136.24) (2010) (1)
- A role for gC1qR/p33 in Francisella tularensis pathogenesis (2018) (1)
- Chapter 3 – C1q (2018) (1)
- Book Review:Complement: A Practical Approach Alister W. Dodds, Robert B. Sim (1999) (1)
- Enhanced Serum Complement Activation on Platelets Is Associated with Arterial Thrombosis in Patients with Systemic Lupus Erythematosus (SLE) and Antiphospholipid Antibodies(aPL). (2007) (1)
- The enigma of complement activation in mixed cryoglobulinemia. (2021) (1)
- Faculty Opinions recommendation of Complement--tapping into new sites and effector systems. (2016) (1)
- Tobacco Smoke and Elevated Shear Stress Enhance Classical Pathway Complement Activation on Human Endothelial Cells. (2006) (1)
- Faculty Opinions recommendation of Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. (2013) (1)
- Angioedema and Shear Stress Modulate Endothelial Permeability Through gC1qR (2019) (1)
- Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (1)
- The dual roles of membrane and soluble forms of gC1qR and C1q in the breast cancer microenvironment. (2017) (1)
- 390 Interaction of allergenic pollens with C1q and its significance in allergic inflammation (1996) (1)
- Sir Peter J. Lachmann and Prof. Robert B. Sim: Gone but Will Never Be Forgotten! (2021) (1)
- Activation of the Classical Pathway of Complement by Resting and Shear Stress-Stimulated Human Endothelial Cells. (2005) (1)
- OF COMPLEMENT BY HAGEMAN FACTOR FRAGMENT (1981) (1)
- Blocking gC1q-Receptor Protein Alters L. monocytogenes Invasion in Caco-2 Cells (2004) (1)
- gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema (2021) (1)
- Faculty Opinions recommendation of Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer. (2021) (0)
- MA12.07 gC1qR Expression is Independently Prognostic for Survival Benefit Following Chemotherapy in Mesothelioma (2018) (0)
- C1Q mediates the clearance of apoptotic cells (2000) (0)
- Faculty Opinions recommendation of Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. (2020) (0)
- Faculty of 1000 evaluation for Modeling complement-driven diseases in transgenic mice: Values and limitations. (2016) (0)
- Abstracts of the Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, September 3–6, 2008 (2008) (0)
- Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
- Abstract 5613: Generation of a therapeutic monoclonal antibody for acute myeloid leukemia by employing the U937 cell line as a surrogate antigen (2018) (0)
- Peripheral blood monocytes express surface C1q and its orientation may dictate early events of monocyte to dendritic cell differentiation (134.62) (2009) (0)
- C1q/gC1qR‐Mediated Activation of Extrinsic Coagulation (2022) (0)
- Faculty Opinions recommendation of Complement immune evasion by spirochetes. (2021) (0)
- High Molecular Weight Kininogen Fragments Stimulate the Secretion of Interleukin-1β through the NFκ B, JNK and p38 MAP Kinase Signaling Pathways in Monocytes. (2006) (0)
- Ligation of the C1q receptor, gC1qR/p33, associates with both the αvβ3 integrin and vitronectin and causes protein phosphorylation (2003) (0)
- GC1QR: A NOVEL BIOMARKER ASSOCIATED WITH RISK OF CARDIOVASCULAR EVENTS (2013) (0)
- gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII (2022) (0)
- C1q: A Molecular Bridge to Innate and Adaptive Immunity (2020) (0)
- Faculty of 1000 evaluation for Complement research in the 18th-21st centuries: Progress comes with new technology. (2016) (0)
- Soluble gC1qR/p33 accelerates the rate of complement activation in C1 inhibitor (C1‐INH) deficient serum (2008) (0)
- Identification of a gClq-binding Protein ( gClq-R ) on the Surface of Human Neutrophils Subcellular Localization and Binding Properties in Comparison with the cClq-R (2013) (0)
- Apoptotic Cell Recognition Acts as a Multiligand-Bridging Molecule in C1q Binds Phosphatidylserine and Likely (2008) (0)
- Faculty of 1000 evaluation for Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics. (2016) (0)
- Faculty Opinions recommendation of Targeting the complement pathway as a therapeutic strategy in lung cancer. (2021) (0)
- Purification and partial characterization of a lymphocyte-derived Clq inhibitor (1982) (0)
- Faculty Opinions recommendation of Looking back on the alternative complement pathway. (2020) (0)
- Co-localization of gC1qR with DC-SIGN on the surface of immature dendritic cells (2010) (0)
- gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema (2021) (0)
- Faculty Opinions recommendation of Genetic deficiency of complement component 3 does not alter disease progression in a mouse model of huntington's disease. (2020) (0)
- Platelet activity measurements and numerical simulations of flow induced thrombus formation in cardiovascular pathologies and devices (2006) (0)
- Abstract B076: The effect of C1q and gC1qR in breast cancer: Racial health disparities (2020) (0)
- Faculty Opinions recommendation of The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy. (2021) (0)
- The Factor XI Receptor on Collagen Activated Platelets Is gC1qR/P33. (2005) (0)
- Crystallographic structure of human C1q globular heads (P1) (2008) (0)
- Analysis of the interaction between globular head modules of human C 1 q and its 1 candidate receptor gC 1 qR 2 3 (2016) (0)
- Faculty Opinions recommendation of The production and secretion of complement component C1q by human mast cells. (2020) (0)
- ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
- Faculty Opinions recommendation of Role of the complement system in the tumor microenvironment. (2021) (0)
- comment ‘ Stealth ’ corporate innovation : an emerging threat for therapeutic drug development Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability , data transparency and validation through the scientific peer-review process (2019) (0)
- Faculty Opinions recommendation of A role for immature myeloid cells in immune senescence. (2011) (0)
- Faculty Opinions recommendation of Preliminary results of STELLAR-001, a dose escalation phase I study of the anti-C5aR, IPH5401, in combination with durvalumab in advanced solid tumours. (2021) (0)
- Book Review:Membrane Defenses Against Attack by Complement and Perforins. C. J. Parker (1993) (0)
- Faculty Opinions recommendation of Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. (2021) (0)
- Faculty Opinions recommendation of Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. (2021) (0)
- DevelopmentTrophoblast Invasion and Placental and Tissue Remodeling: Contribution to An Alternative Role of C1q in Cell Migration (2010) (0)
- Faculty Opinions recommendation of Intracellular complement - the complosome - in immune cell regulation. (2020) (0)
- gC1QR/p33 expression in human atherosclerotic lesions (2002) (0)
- Faculty Opinions recommendation of Prognostic implications of the complement protein c1q in gliomas. (2021) (0)
- Crystallographic structure of human C1q globular heads complexed to phosphatidyl-serine (2008) (0)
- Faculty of 1000 evaluation for Complement-coagulation crosstalk on cellular and artificial surfaces. (2016) (0)
- C1q Is Involved in Human Trophoblast Invasion (2007) (0)
- Inflammatory, Thrombotic, and Diabetic Responses in Human Arterial Fibroblasts and Endothelial Cells are Regulated by SARS‐CoV‐2 Structural Proteins (2021) (0)
- Complement component C1q initiates extrinsic coagulation via the receptor for the globular head of C1q in adventitial fibroblasts and vascular smooth muscle cells (2023) (0)
- Faculty of 1000 evaluation for Current treatment options for hereditary angioedema due to C1 inhibitor deficiency. (2016) (0)
- HUMAN NEUTROPHIL C l q RECEPTOR 1641 effect of free Clq on the function of stimulated neutrophils under physiologic conditions (2000) (0)
- Complement Component C1q Initiates Extrinsic Coagulation via gC1qR (2021) (0)
- Faculty of 1000 evaluation for The collectins CL-L1, CL-K1 and CL-P1, and their roles in complement and innate immunity. (2016) (0)
- Vascular Damage Hepatitis C Virus-Related Cryoglobulin of C1q Protein in the Pathogenesis of Role of the Receptor for the Globular Domain (2009) (0)
- SARS-CoV-2 Structural Proteins Exposure Alter Thrombotic and Inflammatory Responses in Human Endothelial Cells (2021) (0)
- C1 Deficiency and Associated Disorders (2020) (0)
- Endothelial Cell Inflammatory Reactions Are Altered in the Presence of E-Cigarette Extracts of Variable Nicotine (2016) (0)
- Faculty of 1000 evaluation for Complement component c1q: historical perspective of a functionally versatile, and structurally unusual, serum protein. (2018) (0)
- Interaction of High Molecular Weight Kininogen with Endothelial Cell Receptors suPAR, gC1qR and Cytokeratin 1 by Surface Plasmon Resonance (BiaCore). (2005) (0)
- Book Review:The Ecology of Health and Disease in Ethiopia. Helmut Kloos, Zein Ahmed Zein (1994) (0)
- Faculty Opinions recommendation of Production of complement components by cells of the immune system. (2020) (0)
- The complex role of kininogens in hereditary angioedema (2022) (0)
- Faculty Opinions recommendation of Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia. (2020) (0)
- Engagement of gC1qR with C1q or mAb induces tumor cell apoptosis (2016) (0)
- Faculty Opinions recommendation of Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. (2020) (0)
- Faculty Opinions recommendation of Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus. (2011) (0)
- Faculty Opinions recommendation of Keeping It All Going-Complement Meets Metabolism. (2020) (0)
- effects of free ligand on activated neutrophils Characterization of the human neutrophil C1q receptor and functional (2011) (0)
- Loss of p32 triggers energy deficiency and impairs goblet cell differentiation in ulcerative colitis (2020) (0)
- Identification of the gC1qR binding sites for HIV-1 gp41 and HCV core protein (2012) (0)
- Faculty Opinions recommendation of Rejection of good manuscripts: possible reasons, consequences and solutions. (2020) (0)
- Activation of the Plasma-Kinin-Forming Cascade Along Cell Surfaces (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Berhane Ghebrehiwet?
Berhane Ghebrehiwet is affiliated with the following schools:
